The largest database of trusted experimental protocols

5 protocols using basic fibroblast growth factor (bfgf)

1

Hematopoietic Differentiation of H1 hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hematopoietic differentiation was performed as previously described (Zhu et al., 2020 (link)). Briefly, H1 hESCs were plated onto Growth Factor Reduced Matrigel (1:200 dilution; BD Biosciences)-coated plates at a proper initial density. The hematopoietic differentiation medium was changed every day, supplemented with corresponding cytokines or inhibitors, and floated hESCs-HSPCs were collected from D8 for further assays. The cytokines or inhibitors added each day were as follows: D0–D1, 40 ng/mL BMP4 (PeproTech), 30 ng/mL Activin A (Sino Biological), 20 ng/mL bFGF (Sino Biological), 6 μM CHIR99021 (Selleck), and 10 μM LY294002 (Selleck); D1–D2, 30 ng/mL BMP4, 1 μM A8301 (Selleck), and 2 μM IWR-1-endo (Selleck); D2–D4, 40 ng/mL vascular endothelial growth factor (VEGF) (Sino Biological) and 50 ng/mL bFGF; D4 and later, 40 ng/mL VEGF, 50 ng/mL bFGF, 10 μM SB431542 (Selleck), 10 ng/mL SCF (PeproTech), 50 ng/mL TPO (Sino Biological), 10 ng/mL IL3 (Sino Biological), 50 ng/mL IL6 (Sino Biological), and 50 ng/mL Flt3L (PeproTech).
+ Open protocol
+ Expand
2

Directed Hematopoietic Differentiation of hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before haematopoietic differentiation, hPSCs were dissociated by Accutase (Sigma) and plated on growth factor‐reduced Matrigel (Corning)‐coated plates with thiazovivin (0.1 μM, Selleck). Firstly, at day 0, 40 ng/ml of BMP4 (Peprotech), 30 ng/ml of ACTIVINA (Sino Biological Inc.), 20 ng/ml of bFGF (Sino Biological Inc.), 6 μM CHIR99021 (Selleck) and 10 μM LY294002 (Selleck) were added to the basic medium (BM, mimics of the CustommTeSR1) of Dulbecco's‐modified Eagle's medium/F‐12 (GIBCO) supplemented with 1% insulin–transferrin–selenium (GIBCO), 70 μg/ml of vitamin C (Sigma). Second, 30 ng/ml of BMP, 1 μM A8301 (Selleck) and 2 μM IWR‐1‐endo (Selleck) were added to the BM on day 1. Then, on days 2–4 of differentiation, 40 ng/ml of vascular endothelial growth factor (Sino Biological Inc.) and 50 ng/ml of bFGF were added to the BM. Finally, 40 ng/ml of vascular endothelial growth factor, 50 ng/ml of bFGF, 10 μM SB431542 (Selleck), 10 ng/ml of stem cell factor (Peprotech), 50 ng/ml of thrombopoietin (Sino Biological Inc.), 10 ng/ml ofinterleukin 3 (Sino Biological Inc.) and 50 ng/ml of interleukin 6 (Sino Biological Inc.) were added in the BM at days 4–6 of differentiation and further haematopoietic commitment and maturation.
+ Open protocol
+ Expand
3

Murine Retinal Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, neural retinal tissues from 8- to 10-week-old mice were digested with 2% dispase at 37 °C for 20 min. The cells were then treated with 0.25% trypsin for 20 min. The dissociated cells were plated onto 2% Matrigel (Coring, Tewksbury, MA)-coated dishes and cultured in basic medium (BM, DMEM/F12 medium supplemented with 1 × N2, 1 × B27, 0.11 mM beta-mercaptoethanol) containing 10 ng/ml bFGF and 2 μM CHIR99021 (Selleck Chemicals, Houston, TX). All tissue culture products were obtained from Thermo Fisher Scientific except where mentioned.
+ Open protocol
+ Expand
4

Hematopoietic Differentiation of hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To initiate hematopoietic differentiation42 (link), the hESCs were passaged with dispase (2 mg mL−1) onto matrigel-coated 12-well plates. These cells were cultured in E6 medium46 (link) plus ACTIVIN A and BMP4 (DMEM/F12 (Hyclone), 64 mg L−1 L­ascorbic acid (Sigma), NaCl (Sigma, adjusting the osmolarity to 340 mOsm), ITS –G (Gibco, 100×) and 50 ng mL−1 ACTIVIN A (Sino biological, 10429-HNAH-50), 50 ng mL−1 BMP4 (Peprotech, 120-05ET)) for 2 days. And then cells were cultured in E6 medium plus 40 ng mL−1 VEGF (Sino biological, 10008-HNAB-50) and 50 ng mL−1 bFGF (Sino biological, 10014-HNAE-50) for next two days. For next 3 days, these cells were cultured in E6 medium plus 40 ng mL−1 VEGF, 50 ng mL−1 bFGF, 10 μM SB431542 (Selleck). After 7 days, these cells were collected for extracting total RNA and FACS analysis for CD34 expression. CD34 antibody conjugated with PerCP-Cy5.5 were used according to the manufacturer’s recommendations.
+ Open protocol
+ Expand
5

Cytokine Signaling Modulates Nanog Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Media used in these experiments, designated “T1”, was LCDMV (used for culturing PC-iPS) minus LIF. Experiments were conducted in 12-well plates (Nunc; 150628), and NANOG tdTomato PC-iPS cells were passaged three times to ensure that NANOG tdTomato was stably expressed. To test the response of each cell line to individual cytokines, the T1 culture medium was supplemented with LIF (Peprotech, 300–05-1) (5 ng/mL, 10 ng/mL), IL-6 (R&D, 206-IL) (50 ng/mL, 100 ng/mL), IGF1 (Peprotech, 100-11-1000) (50 ng/mL, 100 ng/mL), bFGF (Peprotech, D2017) (5 ng/mL, 10 ng/mL), Activin A (Peprotech, 1017) (5 ng/mL, 10 ng/mL), or BMP4 (Peprotech, 120-05ET) (5 ng/mL, 10 ng/mL). The corresponding signal pathway inhibitors were as follows: 10 μM ruxolitinib (INCB018424) (Selleck, S1378) (Jak-STAT pathway inhibitor), 10 μM Ly294002 (S1737 1 mg) (PIP3-AKT pathway inhibitor), 10 μM AZD4547 (Selleck, S2801) (bFGF-ERK pathway inhibitor), 10 μM SB431542 (Selleck, S1067) (TGF-β/Activin A pathway inhibitor), and Noggin (R&D, 6057-NG-025) (antagonist of BMP4) (50 ng/mL and 100 ng/mL). Fluorescence microscopy, flow cytometry, and RT-PCR were done to detect expression of NANOG tdTomato.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!